ConductScience.org, home

Paper326117

Cis-diamminedichloroplatinum (II). A new anticancer drug.

Rozencweig M and 3 others. Ann Intern Med, 1977. Cited by 513 papers, by iCite.

Cite this record

ConductScience Library. Cis-diamminedichloroplatinum (II). A new anticancer drug. Papers, record 326117. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/326117

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cis-diamminedichloroplatinum (II). A new anticancer drug.
PubMed
Journal
Ann Intern Med
PubMed
Year
1977
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
513
iCite
Relative citation ratio, by iCite
16.9
iCite
Revised in PubMed
2019-06-19
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rozencweig MM
2von Hoff DDD D
3Slavik MM
4Muggia FMF M

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CisplatinMajor topic
NeoplasmsMajor topic
Child
Colonic Neoplasms
Female
Head and Neck Neoplasms
Hearing Disorders
Humans
Kidney Diseases
Male
Nausea
Ovarian Neoplasms
Testicular Neoplasms
Urinary Bladder Neoplasms
Vomiting

Source PubMed

Download CSV of topics

Cited by80

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 513 citations.

PMIDTitleJournalYearIn PapersSource
41562768Cisplatin as a Xenobiotic Agent: Molecular Mechanisms of Actions and Clinical Applications in Oncology.J Xenobiot2026https://conductscience.org/library/papers/41562768PubMed
40956032Metabolic Reprogramming of Cancer Cells and Therapeutics Targeting Cancer Metabolism.Cancer Med2025https://conductscience.org/library/papers/40956032PubMed
40649349Synthesis, Structure, Electrochemistry, and In Vitro Anticancer and Anti-Migratory Activities of (Z)- and (E)-2-Substituted-3-Ferrocene-Acrylonitrile Hybrids and Their Derivatives.Molecules2025https://conductscience.org/library/papers/40649349PubMed
39905500Intratympanic N-acetylcysteine in the prevention of cisplatin-induced ototoxicity: a systematic review and meta-analysis of randomized controlled trials.BMC Pharmacol Toxicol2025https://conductscience.org/library/papers/39905500PubMed
38885368Anti-Quenching NIR-II Excitation Phenylboronic Acid Modified Conjugated Polyelectrolyte for Intracellular Peroxynitrite-Enhanced Chemo-Photothermal Therapy.Adv Sci (Weinh)2024https://conductscience.org/library/papers/38885368PubMed
38424294Pharmacodynamics and biodistribution of [195mPt]cisplatin(CISSPECT®) in head and neck squamous cell carcinoma.EJNMMI Res2024https://conductscience.org/library/papers/38424294PubMed
36618350Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics.Front Immunol2022https://conductscience.org/library/papers/36618350PubMed
36615466Highlights of New Strategies to Increase the Efficacy of Transition Metal Complexes for Cancer Treatments.Molecules2022https://conductscience.org/library/papers/36615466PubMed
35829930Property evaluation of two anticancer candidate platinum complexes with N-isobutyl glycine ligand against human colon cancer.Biometals2022https://conductscience.org/library/papers/35829930PubMed
35632435Renal Function Outcomes in Metastatic Non-Small-Cell Lung Carcinoma Patients Treated with Chemotherapy or Immune Checkpoint Inhibitors: An Unexpected Scenario.Vaccines (Basel)2022https://conductscience.org/library/papers/35632435PubMed
35528662The role of hollow magnetic nanoparticles in drug delivery.RSC Adv2019https://conductscience.org/library/papers/35528662PubMed
35477416Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy.J Hematol Oncol2022https://conductscience.org/library/papers/35477416PubMed
33761993The combination of G-CSF and AMD3100 mobilizes bone marrow-derived stem cells to protect against cisplatin-induced acute kidney injury in mice.Stem Cell Res Ther2021https://conductscience.org/library/papers/33761993PubMed
32708025Phosphorus Dendrimers as Nanotools against Cancers.Molecules2020https://conductscience.org/library/papers/32708025PubMed
30682873Oxaliplatin-Based Intra-arterial Chemotherapy in Colo-Rectal Cancer Liver Metastases: A Review from Pharmacology to Clinical Application.Cancers (Basel)2019https://conductscience.org/library/papers/30682873PubMed
27721894The Fruit Hull of Gleditsia sinensis Enhances the Anti-Tumor Effect of cis-Diammine Dichloridoplatinum II (Cisplatin).Evid Based Complement Alternat Med2016https://conductscience.org/library/papers/27721894PubMed
25982100Insights into the structure-activity relationships of chiral 1,2-diaminophenylalkane platinum(II) anticancer derivatives.J Biol Inorg Chem2015https://conductscience.org/library/papers/25982100PubMed
25020203Risk factors for cisplatin-induced nephrotoxicity and potential of magnesium supplementation for renal protection.PLoS One2014https://conductscience.org/library/papers/25020203PubMed
24283498Synthetic methods for the preparation of platinum anticancer complexes.Chem Rev2014https://conductscience.org/library/papers/24283498PubMed
23122180Ototoxicity in dogs and cats.Vet Clin North Am Small Anim Pract2012https://conductscience.org/library/papers/23122180PubMed

See all 80 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/326117

GET https://conductscience.org/api/papers/v1/326117/cited_by?page=2